NO20085045L - Benzoksazol and benzotiazol derivativer som 5-hydroksytrytamin-6 ligander - Google Patents

Benzoksazol and benzotiazol derivativer som 5-hydroksytrytamin-6 ligander

Info

Publication number
NO20085045L
NO20085045L NO20085045A NO20085045A NO20085045L NO 20085045 L NO20085045 L NO 20085045L NO 20085045 A NO20085045 A NO 20085045A NO 20085045 A NO20085045 A NO 20085045A NO 20085045 L NO20085045 L NO 20085045L
Authority
NO
Norway
Prior art keywords
hydroxytrythamine
benzoxazole
ligands
benzothiazole derivatives
benzothiazole
Prior art date
Application number
NO20085045A
Other languages
English (en)
Inventor
Albert J Robichaud
Kevin Liu
Hassan Mahmoud Elokdah
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20085045L publication Critical patent/NO20085045L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/423—Oxazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Foreliggende oppfinnelse tilveiebringer en forbindelse med formel I og anvendelsen derav for behandling av en sentralnervesystemlidelse relatert til eller påvirket av 5-HT6 reseptoren.
NO20085045A 2006-06-01 2008-12-03 Benzoksazol and benzotiazol derivativer som 5-hydroksytrytamin-6 ligander NO20085045L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80999606P 2006-06-01 2006-06-01
PCT/US2007/012569 WO2007142904A2 (en) 2006-06-01 2007-05-25 Benzoxazole and benzothiazole derivatives as 5-hydroxytrytamine-6 ligands

Publications (1)

Publication Number Publication Date
NO20085045L true NO20085045L (no) 2008-12-12

Family

ID=38668755

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20085045A NO20085045L (no) 2006-06-01 2008-12-03 Benzoksazol and benzotiazol derivativer som 5-hydroksytrytamin-6 ligander

Country Status (17)

Country Link
US (1) US7501421B2 (no)
EP (1) EP2024348A2 (no)
JP (1) JP2009538909A (no)
KR (1) KR20090023641A (no)
CN (1) CN101490022A (no)
AR (1) AR061147A1 (no)
AU (1) AU2007255041A1 (no)
BR (1) BRPI0712444A2 (no)
CA (1) CA2659701A1 (no)
CR (1) CR10474A (no)
EC (1) ECSP088930A (no)
IL (1) IL195590A0 (no)
MX (1) MX2008015328A (no)
NO (1) NO20085045L (no)
PE (1) PE20080707A1 (no)
TW (1) TW200804310A (no)
WO (1) WO2007142904A2 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102574786A (zh) * 2009-04-02 2012-07-11 默克雪兰诺有限公司 二氢乳清酸脱氢酶抑制剂
KR101250606B1 (ko) * 2011-01-24 2013-04-03 이화여자대학교 산학협력단 5-ｈｔ６ 수용체 억제 작용을 갖는 신규한 벤조티아졸 및 벤즈이소티아졸유도체, 이의 제조 방법 및 이를 포함하는 약학적 조성물
TWI670267B (zh) * 2013-07-10 2019-09-01 日商明治製菓藥業股份有限公司 新穎ｐｄｅ４抑制劑
SG11201610407QA (en) 2014-07-08 2017-01-27 Sunshine Lake Pharma Co Ltd Aromatic heterocyclic derivatives and pharmaceutical applications thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7582635B2 (en) * 2002-12-24 2009-09-01 Purdue Pharma, L.P. Therapeutic agents useful for treating pain
GB0422263D0 (en) * 2004-10-07 2004-11-10 Glaxo Group Ltd Novel compounds

Also Published As

Publication number Publication date
CR10474A (es) 2009-01-07
US20070281945A1 (en) 2007-12-06
WO2007142904A3 (en) 2008-02-07
PE20080707A1 (es) 2008-05-22
CN101490022A (zh) 2009-07-22
KR20090023641A (ko) 2009-03-05
CA2659701A1 (en) 2007-12-13
TW200804310A (en) 2008-01-16
AU2007255041A1 (en) 2007-12-13
MX2008015328A (es) 2008-12-12
AR061147A1 (es) 2008-08-06
ECSP088930A (es) 2009-01-30
EP2024348A2 (en) 2009-02-18
WO2007142904A2 (en) 2007-12-13
BRPI0712444A2 (pt) 2012-06-05
JP2009538909A (ja) 2009-11-12
US7501421B2 (en) 2009-03-10
IL195590A0 (en) 2009-09-01

Similar Documents

Publication Publication Date Title
NO20050007L (no) 1-Heterosyklylalkyl-3-sulfonylazaindol eller -azaindazolderivater som 5-hydroksytryptamin-6 ligander
NO20050014L (no) 1-Heterosyklylalkyl-3-sulfonylindol eller -indazolderivater som 5-hydroksytryptamin-6 ligander
WO2007142905A3 (en) 1-sulfonylindazolylamine and -amide derivatives as 5-hydroxytryptamine-6 ligands
ATE478072T1 (de) Spiroimidazol-derivate als ppar-modulatoren
NO20083058L (no) Cykloheksylsulfonamidderivater med H3 reseptor aktivitet
NO20082136L (no) 1,5-substituerte indol-2-yl-amidderivater
NO20085288L (no) Nye karbonylerte (aza)cykloheksaner som dopamin D3 reseptorligander
NO20085385L (no) Tiazolforbindelser som cannabinoidreseptorligander og anvendelser derav
NO20082090L (no) Pyridopyrimidinoninhibitorer av P13K alfa
EA200901488A1 (ru) Замещенные имидазолопиридазины, как ингибиторы липидкиназы
NO20082096L (no) Azaindol-2-karboksamidderivativer
MA32508B1 (fr) Composes organiques
EA201200174A1 (ru) Производные оксазина и их применение в качестве ингибиторов bace для лечения неврологических нарушений
NO20092004L (no) 2-[L-fenyl-5-hydroksy-4-alfa-metyl-heksahydrosyklopenta[f]indazol-5-yl]etylfenylderivater som glukokortikoidreseptorligandere
NO20075082L (no) Pyridin-3-karboksamidderivater som CB1-inversagonister
DK2040713T3 (da) Galdesyrederivater som fxr-ligander til forebyggelsen eller behandlingen af fxr-medierede sygdomme eller tilstande
NO20082939L (no) Sykloheksyl piperasinyl metanon derivater og anvendelse av disse som histamin H3 reseptor modulatorer
NO20082285L (no) 3-aminosyklopentankarboksamider som modulatorer av kjemokinreseptorer
MX2010002899A (es) Derivados de azaciclilisoquinolinona e isoindolinona como antagonistas de la histamina-3.
NO20092048L (no) Nye benzamidderivater som bradykininantagonister
NO20082214L (no) 1,1-Diokso-tiomorfolinyl-indolyl-metanonderivater for anvendelse som H3-modulatorer
ATE466854T1 (de) 1h-indol-6-ylpiperazin-1-ylmethanonderivate zur verwendung als h3-rezeptormodulatoren
NO20084301L (no) Tetrahydronaftalenderivater, fremgangsmate for deres fremstilling og anvendelse derav som anti-inflammatoriske midler
NO20080937L (no) Substituerte-3-sulfonylindazolderivater som 5-hydroksytryptamin-6-ligander
UY31527A1 (es) Derivados ciclopropilamina

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application